Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Skin and hair aging involves mitochondrial issues, telomere shortening, and hormonal changes, with iron affecting hair loss in pre-menopausal women.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Minoxidil helps hair regrowth in traction alopecia.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Hair loss in this case was caused by a tumor, not typical baldness.

PC-associated alopecia has unique microscopic features.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Densitometry and video-microscopy are precise for evaluating hair loss and transplant success but need special equipment and training.

Apoptosis may contribute to hair loss in androgenetic alopecia.

The document concludes that hair follicles have a complex environment and our understanding of it is growing, but there are limitations when applying animal study findings to humans.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Polymeric micelles offer a promising new way to treat hair loss with fewer side effects.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Diffuse unpatterned alopecia can affect donor areas, but treatment with finasteride and minoxidil can improve hair density.

Regenerative therapies could help treat hair loss in androgenetic alopecia.

Regenerative therapies may help treat hair loss in androgenetic alopecia.

Regenerative therapies could help treat hair loss in androgenetic alopecia.

Current treatments can slow hair loss and promote regrowth, with hair transplantation being most effective for advanced cases.

Current treatments can slow hair loss and promote regrowth, with hair transplantation being most effective for advanced cases.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

The treatment improved hair density and scalp coverage in an elderly woman with hair loss.

The treatment improved hair density and scalp coverage in an elderly woman with hair loss.